Zobrazeno 1 - 10
of 230
pro vyhledávání: '"David J Ross"'
Publikováno v:
Biomarker Insights, Vol 15 (2020)
Externí odkaz:
https://doaj.org/article/3e1579a69f644358ab2408238c691af5
Autor:
Anna-Maria Hoffmann-Vold, Stephen Samuel Weigt, Vyacheslav Palchevskiy, Elizabeth Volkmann, Rajan Saggar, Ning Li, Øyvind Midtvedt, May Brit Lund, Torhild Garen, Michael C Fishbein, Abbas Ardehali, David J Ross, Thor Ueland, Pål Aukrust, Joseph P Lynch, Robert M Elashoff, Øyvind Molberg, John A Belperio
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206545 (2018)
BACKGROUND:Dysregulation of Fractalkine (CX3CL1) and its receptor CX3CR1 has been linked to the pathobiology of chronic inflammatory conditions. We explored CX3CL1 in systemic sclerosis (SSc) related progressive interstitial lung disease (ILD) and pu
Externí odkaz:
https://doaj.org/article/35807d8610404e829ad34bc846b6ab31
Autor:
S Samuel Weigt, Xiaoyan Wang, Vyacheslav Palchevskiy, Aric L Gregson, Naman Patel, Ariss DerHovanessian, Michael Y Shino, David M Sayah, Shirin Birjandi, Joseph P Lynch, Rajan Saggar, Abbas Ardehali, David J Ross, Scott M Palmer, David Elashoff, John A Belperio
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169894 (2017)
BACKGROUND:Chronic Lung Allograft Dysfunction (CLAD) is the main limitation to long-term survival after lung transplantation. Although CLAD is usually not responsive to treatment, earlier identification may improve treatment prospects. METHODS:In a n
Externí odkaz:
https://doaj.org/article/51c2cfff00ed41e99d5e67da95b3a38c
Autor:
Michael Y Shino, S Samuel Weigt, Ning Li, Vyacheslav Palchevskiy, Ariss Derhovanessian, Rajan Saggar, David M Sayah, Richard H Huynh, Aric L Gregson, Michael C Fishbein, Abbas Ardehali, David J Ross, Joseph P Lynch, Robert M Elashoff, John A Belperio
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180281 (2017)
Since the pathogenesis of chronic lung allograft dysfunction (CLAD) remains poorly defined with no known effective therapies, the identification and study of key events which increase CLAD risk is a critical step towards improving outcomes. We hypoth
Externí odkaz:
https://doaj.org/article/f26eb751205e4bdab74fb06f6ebd3e38
Autor:
Ambalavanan Arunachalam, Fatima Anjum, Justin P. Rosenheck, Reinaldo Rampolla, Reda Girgis, Howard J. Huang, Kathryn Crabtree, Sarah McCormick, Zhiji Zhang, Sangeeta Bhorade, David J. Ross
Publikováno v:
JHLT Open, Vol 6, Iss , Pp 100155- (2024)
Background: Donor-derived cell-free DNA (dd-cfDNA) is a nonspecific plasma biomarker for tissue injury that has been validated for monitoring acute rejection (AR) after lung transplantation (LT). However, no studies to date have focused specifically
Externí odkaz:
https://doaj.org/article/06a2473bbfdf43a6a01e4fa131b8062f
Publikováno v:
Transplantation Reports, Vol 7, Iss 3, Pp 100106- (2022)
Background: Chronic lung allograft dysfunction (CLAD) is a highly prevalent and devastating complication in lung transplant (LT), culminating in increased allograft failure, morbidity, and mortality. Determination of the fraction of plasma donor-deri
Externí odkaz:
https://doaj.org/article/89afa3fb30494295959ce02a31081ec2
Autor:
Thomas Bertero, Yu Lu, Sofia Annis, Andrew Hale, Balkrishen Bhat, Rajan Saggar, Rajeev Saggar, W. Dean Wallace, David J. Ross, Sara O. Vargas, Brian B. Graham, Rahul Kumar, Stephen M. Black, Sohrab Fratz, Jeffrey R. Fineman, James D. West, Kathleen J. Haley, Aaron B. Waxman, B. Nelson Chau, Katherine A. Cottrill, Stephen Y. Chan
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 10 (2022)
Externí odkaz:
https://doaj.org/article/f75ae1b920ed4388b4b98edd05c4de18
Publikováno v:
Kidney Research and Clinical Practice, Vol 39, Iss 4, Pp 495-500 (2020)
Background : Donor-derived, cell-free DNA (dd-cfDNA) level correlates with allograft injury with clinical validity and utility for quiescence and active acute rejection (AR) in kidney transplant recipients. We analyzed trends in dd-cfDNA level immedi
Externí odkaz:
https://doaj.org/article/55f29bd10ec047b7b8a176c48178dd55
Autor:
Justin P. Rosenheck, DO, David J. Ross, MD, Mena Botros, MD, Alexander Wong, MD, Jonathan Sternberg, PhD, Yen-An Chen, MS, Nathan Liang, BA, Amy Baer, MS, Ebad Ahmed, PhD, Ryan Swenerton, PhD, Bernhard G. Zimmermann, PhD, Gordon Fehringer, PhD, Zachary P. Demko, PhD, Michael Olymbios, MD, Paul R. Billings, MD, PhD, Brian C. Keller, MD, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 4, p e1317 (2022)
Background. Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD)
Externí odkaz:
https://doaj.org/article/9edea27d61424d5caf9b33424f5d3cb2
Autor:
Rajeev Saggar, Paresh C. Giri, Chunqin Deng, Dana Johnson, Mary K. McCloy, Lloyd Liang, Faisal Shaikh, Jason Hong, Richard N. Channick, Shelley S. Shapiro, Joseph P. Lynch, John A. Belperio, Samuel S. Weigt, Allison L. Ramsey, David J. Ross, David M. Sayah, Michael Y. Shino, Ariss Derhovanessian, Alexander E. Sherman, Rajan Saggar
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
The association of autoimmune disease (AI) with transplant-free survival in the setting of severe Group 3 pulmonary hypertension and extensive pulmonary fibrosis remains unclear. We report cases of severe pulmonary hypertension (mean pulmonary artery
Externí odkaz:
https://doaj.org/article/de848169b58d43ad9c6dc063d0502e7c